Log In
Print
BCIQ
Print
Print this Print this
 

reparixin (formerly repertaxin)

  Manage Alerts
Collapse Summary General Information
Company Dompe Farmaceutici S.p.A.
DescriptionCXC chemokine receptor 1 (CXCR1) and CXCR2 inhibitor
Molecular Target CXC chemokine receptor 1 (CXCR1) ; CXC chemokine receptor 2 (CXCR2) (IL8RB)
Mechanism of ActionCXC chemokine receptor 2 (CXCR2) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today